The VAD Scheme versus Thalidomide plus VAD for Reduction of Vascular Endothelial Growth Factor in Multiple Myeloma: A Meta-Analysis

Figure 3

Forest plot comparing serum VEGF between MM patients before treatment and a nontumor control group.